Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Infinity Pharmaceuticals (NASDAQ:INFI): The shares closed at $7.05, up $0.71, or 11.2%, on the day. Its market capitalization is $187.55 million. About the company: Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.
  • Genomic Health, Inc. (NASDAQ:GHDX): The shares closed at $21.98, up $2.03, or 10.18%, on the day. Its market capitalization is $648.24 million. About the company: Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company’s diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.
  • Simcere Pharmaceutical (NYSE:SCR): The shares closed at $9.93, up $0.78, or 8.52%, on the day. Its market capitalization is $535.27 million. About the company: Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company’s products include antibiotics, anti-cancer medications and anti-stroke medications.
  • Pharmasset, Inc. (NASDAQ:VRUS): The shares closed at $82.37, up $5.07, or 6.56%, on the day. Its market capitalization is $6.21 billion. About the company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • Antares Pharma Inc (AMEX:AIS): The shares closed at $2.32, up $0.09, or 4.04%, on the day. Its market capitalization is $239.57 million. About the company: Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Losers (% price change)

  • ISTA Pharmaceuticals, Inc (NASDAQ:ISTA): The shares closed at $3.45, down $0.36, or 9.45%, on the day. Its market capitalization is $144.41 million. About the company: Ista Pharmaceuticals, Inc. develops proprietary therapeutic products that save and improve eyesight. The Company’s product candidates and programs address diseases and conditions such as vitreous hemorrhage, diabetic retinopathy, glaucoma, ocular pain, and inflammation.
  • Savient Pharmaceuticals (NASDAQ:SVNT): The shares closed at $4.10, down $0.38, or 8.48%, on the day. Its market capitalization is $292.73 million. About the company: Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology.
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $12.69, down $1.04, or 7.57%, on the day. Its market capitalization is $2.42 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.
  • Kindred Healthcare, Inc. (NYSE:KND): The shares closed at $8.62, down $0.63, or 6.81%, on the day. Its market capitalization is $449.21 million. About the company: Kindred Healthcare, Inc. is a national healthcare services company operating hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business.
  • InterMune, Inc. (NASDAQ:ITMN): The shares closed at $20.20, down $1.47, or 6.78%, on the day. Its market capitalization is $1.23 billion. About the company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>